A number of studies have shown an association between the rs1142345 and rs1800460 markers of the TPMT gene and an increased susceptibility to grave toxicity during the treatment of ALL with 6-MP20–22. This evidence concerns the gene TPMT and acute lymphoblastic leukemia.